Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung

Advanced Breast Cancer

Squamous Cell Carcinoma of Head and Neck

Digestive System Neoplasms

Triple Negative Breast Neoplasms

Solid Tumors

Advanced Solid Tumors

Advanced Solid Tumors Cancer

Advanced Solid Tumor

Lung Neoplasms, Ovarian Neoplasms

Advanced Solid Tumor (Phase 1)

Non-Muscle Invasive Bladder Neoplasms

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

Advanced Gynecological Malignancies

Advanced Endometrial Cancer

Advanced Endometrial Cancer

Pancreatic Neoplasms

Metastatic Solid Tumors

CLDN18.2-positive Advanced Biliary Tract Cancer

Malignant Solid Tumor

Small Cell Lung Carcinoma

Breast Neoplasms, Lung Neoplasms, Colorectal Neoplasms

Adenocarcinoma

Breast Neoplasms

Pancreatic Neoplasms

Advanced Solid Tumors

Nasopharyngeal Neoplasms, Recurrence

Pancreatic Neoplasms

Breast Neoplasms

Carcinoma, Non-Small-Cell Lung

Melanoma, Sarcoma

Advanced Pancreatic Cancer

Neoplasm Metastasis, Leukemia, Myeloid, Acute

Carcinoma, Hepatocellular

Advanced or Metastatic Solid Tumors

Clinical Trials

Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK202 for Injection in Combination With Drugs in NSCLC Participants.

A Phase II Study of AK146D1 Combined With AK112 in Advanced Breast Cancer

Pucotenlimab Plus Becotatug Vedotin in Perioperative Treatment of Locally Advanced Resectable Head and Neck Squamous Cell Carcinoma

A Study of SKB571 in Participants With Gastrointestinal Tumors

A Study of BEBT-209 Plus Chemotherapy in Patients With Locally Advanced or Metastatic Triple-Negative Breast Cancer

A I/II Phase Clinical Study to Evaluate the Safety and Efficacy of RC288 in the Treatment of Solid Tumors

A Phase Ib/II Study Evaluating Injectable ALK-N001 in Patients With Advanced Solid Tumors

First-In-Human Study of KHN922 for Injection

Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors

CYTALUX Dose Extension Study

Evaluation of T320, an Anti-Tissue Factor Antibody-Drug Conjugate, in Patients With Advanced Solid Tumors

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma

INJECTABL-3

Phase IIa Study of BRY812 Monotherapy in Advanced Gynecological Malignancies

Efficacy and Safety of a Repurposed Drug Added to the Combination of Len Plus Pem in Advanced Endometrial Cancer

Safety Lead-In Study of a Repurposed Drug Added to the Combination of Len Plus Pem

Phase III Study to Compare GFH375 and Chemotherapy in Patients With KRAS G12D-Mutant Metastatic Pancreatic Cancer

A Study of BPR-6023021 in Advanced Solid Tumors With Bone Metastases

Combination of QLS31905 and Chemotherapy ± QL2107 in Patients With CLDN18.2-positive Advanced Biliary Tract Cancer

A Phase I/II Clinical Study of FH-006 for Injection in Patients With Malignant Solid Tumors

A Phase II/III Study of IBB0979 in Combination With Topotecan Versus Topotecan in Relapsed Small Cell Lung Cancer

To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant Tumors

Combination of QLS31905, QL2107 and Chemotherapy as First-line Therapy in CLDN18.2-positive Unresectable Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Sirolimus for Injection (Albumin-bound) Combined With Fulvestrant for HR+/HER2- Advanced/Metastatic Breast Cancer Patients Previously Treated With CDK4/6 Inhibitors

A Study of mRNA Vaccines AK154 Monotherapy or in Combination With AK104/AK112,and Sequential mFOLFIRINOX in Surgically Resected PDAC

First-In-Human Study in Participants With Advanced Solid Tumors

JMT101 Combined With Mitoxantrone Liposome for Nasopharyngeal Cancer

YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer

A Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Investigator-Selected Chemotherapy in HER2 Low-Expressing Recurrent/Metastatic Breast Cancer

Study of BEBT-109 in Subjects With Non-Small Cell Lung Cancer Carrying EGFR Exon 20 Insertion Mutations

TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors

A Study of Docetaxel for Injection (Albumin Bound) in Patients With Advanced Pancreatic Cancer

A Bridging Study of Liposomal Cytarabine-Daunorubicin in Treating Olderly Patients With Treatment-naive High-Risk (Secondary) Acute Myeloid Leukemia

Clinical Study of VG161 Combined With Camrelizumab in Patients With Advanced Primary Hepatocellular Carcinoma

Study of MHB088C in Participants With Advanced or Metastatic Solid Tumors